X4 Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.80-$4.83 |
Market Cap | $412.4M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $15.8M |
Revenue Growth (YoY) | 346.3% |
Gross Profit (12 Mos) | $12.9M |
Diluted EPS | $1.46 |
News
See moreYahoo Finance • 2 months ago
X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors
Yahoo Finance • 5 months ago
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Yahoo Finance • 6 months ago
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CFO | Mr. David H. Kirske |
Address | 61 North Beacon Street, Boston, MA, United States, 02134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 45 |